Cosmetic cross-reference Noindex: medium evidence

Decanal

CAS 112-31-2

Decanal (CAS 112-31-2) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Decanal

CAS Number

112-31-2

UNII

31Z90Q7KQJ

InChIKey

KSMVZQYAVGTKIV-UHFFFAOYSA-N

ChEMBL ID

CHEMBL2228377

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Decanal used for in pharmaceutical contexts?

Decanal (CAS 112-31-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Decanal?

No adverse-event association or SIDER side-effect rows are rendered for Decanal in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Decanal also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Decanal with EU status "restricted".

What clinical phase is Decanal in?

No phase 1-4 clinical development badge is rendered for Decanal because the matched compound identifier rows do not contain a max-phase value.